Exfoliative urinary cytology was performed on 260 new cases of histologically proven urothelial cancer. The site, size, shape and histological grade of the tumours were documented, and they were classified by the TNM system. Overall, urine cytology was positive in 135 (52%), suspicious in 28 (11%) and negative in 97 (38%) cases. Malignant cells were found most often when the urothelial tumours were large, papillary and solid, moderately or poorly differentiated and invasive (T2-4). Most upper tract tumours and those situated in bladder diverticula had positive urinary cytology. This study confirms that exfoliative urinary cytology is useful in detecting the more malignant bladder tumours including insitu carcinoma, and other tumours in less accessible parts of the urinary tract.
Introduction
The accuracy of exfoliative urine cytology in the diagnosis ofurothelial neoplasia has been assessed in a number of studies since the value of this examination was firmly established by Papanicolaou'. In most studies comparisons were made with the histological grade of urothelial tumours, and it is generally accepted that well differentiated tumours are difficult to identify with exfoliative urine cytology, since the individual tumour cells are virtually indistinguishable from normal urothelial cells. However, figures for overall sensitivity of urine cytology have varied from 41%2 to 100%', averaging around 60%4.
We have, therefore, reviewed the accuracy of our urinary cytology in urothelial tumours, looking in more detail at other features such as site, size, shape and TNM classification, as well as histological grade.
It was our intention to reassess the role of exfoliative urine cytology in the present-day management of urothelial cancer, particularly with regard to diagnosis of new tumours in patients presenting to our haematuria services, and additionally, by inference, to assess its potential reliability in following up patients who have been clear of recurrence for some years by outpatient cytological surveillance.
Patients and methods A single random urine sample was sent for cytological examination in 260 patients presenting with histologically proven urothelial carcinomas. All patients were assessed by intravenous urography, cystoscopy with biopsy, and bimanual examination under general anaesthesia. The site, size and shape of all tumours was recorded on specially designed computer sheets5, and the TNM classification of bladder tumours was derived from the depth of penetration of the bladder wall assessed histologi-cally in biopsy specimens together with the findings on bimanual examination6. All tumours were graded as well differentiated, moderately well or poorly differentiated according to the WHO classification7. Urine specimens were sent directly from the Outpatients Department to the Cytology Laboratory in order to minimize delay and thus maintain as far as possible the integrity of the cells in the urine. Cloudy urine was treated with acetic acid to clear phosphates, and by gentle heating to clear urates. If the urine was still cloudy after this treatment a smear from the centrifugal deposit was prepared. With clear urine, a millipore filter specimen was prepared, and the filtrate was stained by Papanicolaou's method.
Results
The urine cytology was positive in 135 (52%), suspicious in 28 (11%) and negative in 97 (37%) of the 260 cases.
The results are related to the site of the primary tumour in Figure 1 , and the numbers of patients are shown. Higher pick-up rates were found with upper tract tumours, although numbers were small: 72% of 14 tumours in the renal pelvis had positive or suspicious cytology, and all 4 ureteric tumours were positive. A good pick-up rate was also found with tumours in bladder diverticula, 83% of which produced positive or suspicious cells in the urine. The poorest group, only 66% positive or suspicious, was found with bladder: fortunately this group is the easiest to diagnose at cystoscopy.
Fewer than one-third of tumours less than 1 cm in diameter produced positive urine cytology ( Figure  2) ; however, progressively higher pick-up rates were seen with larger tumours.
Purely papillary tumours were not easily diagnosed by urine cytology: only 52% were positive or suspicious ( Figure 3 ). More surprisingly, solid tumours gave a rather poor yield as wellonly 63% positive or suspiciousperhaps because of a rather necrotic surface. However, 86% of 65 mixed papillary and solid tumours produced malignant or suspicious cells in the urine.
A progression in sensitivity of cytology was clearly demonstrable with advancing T stage: only 47% of 115 TA tumours had positive or suspicious cytology, whereas 70%, 83%, 73% and 100% of Ti, T2, T3 and T4 tumours were positive or suspicious respectively. Furthermore, 4 (80%) of 5 flat, in-situ carcinomas (TiS) were positive.
The clearest association of all was between urine cytology and the histological grade of tumour (Figure 4 ). Only 41% of Gi tumours were suspicious or positive, compared to 66% of G2 and 82% of G3 tumours respectively. 
Discussion
The results of exfoliative urine cytology in the diagnosis of urothelial cancer in this study are remarkably similar to those reported by Esposti et al.8, who found 51% positive, 16% suspicious and 32% negative amongst 170 untreated bladder tumours. In both studies the most important determinant was the histological grade of the tumour, urine cytology being positive in 82% and 86% of poorly differentiated tumours in these two studies. On the other hand, only 40% of well differentiated tumours were diagnosed cytologically. It follows that this examination cannot replace the well tested methods of intravenous urography and cystoscopy in the diagnosis of these tumours. Nevertheless, detailed analysis has indicated that urine cytology has a very useful supplementary role, a conclusion also reached in a recent study by Murphy et al. 9 .
Upper tract tumours may be difficult to diagnose with certainty, and they may develop at any time in patients being followed up for carcinoma of bladder by regular check cystoscopies. It is particularly reassuring to find that urine cytology was positive in many patients with these difficult tumours, perhaps due to the peristaltic activity of the renal pelvis and ureter massaging cells into the urine. Similarly, the high pick-up rate with tumours in diverticula was reassuring, since these may be overlooked at routine check cystoscopy.
These findings suggest that urine cytology should always be done at the same time as check cystoscopy: an unexpectedly positive result may alert the urologist to the presence oftumour in an inaccessible site, or alternatively to the development of carcinoma-in-situ in the bladder, which may not be recognized at cystoscopy unless mucosal biopsies are taken. Fortunately, this ominous change in the bladder mucosa is nearly always associated with positive urine cytology. Previously unreported is the higher incidence of positive urine cytology in papillary and solid tumours than in papillary well differentiated tumours, and even in solid poorly differentiated tumours, which often have extensive surface necrosis. This is of particular interest, since the urologist may not recognize cystoscopically the more sinister parts of papillary tumours, and yet these growths can be 'wolves in sheep's clothing', ultimately leading to the patient's death. The presence of strongly positive urine cytology should, therefore, alert the urologist to the malignant course that the tumour may pursue, allowing early use of more radical adjuvant therapy in cases with an ominous prognosis. Of course, this may be simply a reflection of poorer differentiation of the tumour cells, but these factors provide strong evidence that the tumour is likely to be active.
